Soleno Therapeutics Inc
NASDAQ:SLNO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Soleno Therapeutics Inc
NASDAQ:SLNO
|
US |
|
F
|
Fairfax Financial Holdings Ltd
BMV:FFHN
|
CA |
|
SIG Group AG
SIX:SIGN
|
CH |
|
Kopran Ltd
NSE:KOPRAN
|
IN |
|
S
|
Somboon Advance Technology PCL
SET:SAT
|
TH |
|
COPT Defense Properties
NYSE:CDP
|
US |
|
P
|
Palfinger AG
F:PFI
|
AT |
|
N
|
Nucletron Electronic AG
XBER:NUC
|
DE |
|
P
|
Paladin Energy Ltd
DUS:PUR
|
AU |
|
Indofood CBP Sukses Makmur Tbk PT
F:48I
|
ID |
|
H
|
Hang Feng Technology Innovation Co Ltd
NASDAQ:FOFO
|
HK |
Wall St Price Targets
SLNO Price Targets Summary
Soleno Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for SLNO is 57.53 USD with a low forecast of 53.53 USD and a high forecast of 84 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is SLNO's stock price target?
Price Target
57.53
USD
According to Wall Street analysts, the average 1-year price target for SLNO is 57.53 USD with a low forecast of 53.53 USD and a high forecast of 84 USD.
What is the Revenue forecast for Soleno Therapeutics Inc?
Projected CAGR
75%
Over the last 12 years, the compound annual growth rate for Revenue has been 41%. The projected CAGR for the next 3 years is 75%.
What is the Operating Income forecast for Soleno Therapeutics Inc?
Projected CAGR
307%
The compound annual growth rate for Operating Income over the next 3 years is 307%.
What is the Net Income forecast for Soleno Therapeutics Inc?
Projected CAGR
188%
The compound annual growth rate for Net Income over the next 3 years is 188%.
